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Abstract
Apoptotic endothelial cells are an important component of the ‘‘response to injury’’ process. Several atherosclerosis risk
factors such as hyperglycemia and oxidized low-density lipoproteins, and immune injuries, such as antibodies and
complement, induce endothelial cell apoptosis. While endothelial cell apoptosis is known to affect neighboring vascular
wall cell biology, its consequences on macrophage reprogramming are ill defined. In this study, we report that apoptosis of
human and mouse endothelial cells triggers the release of milk fat globule-epidermal growth factor 8 (MFG-E8) and
reprograms macrophages into an anti-inflammatory cells. We demonstrated that MFG-E8 is released by apoptotic
endothelial cells in a caspase-3-dependent manner. When macrophages were exposed to conditioned media from serum-
starved apoptotic endothelial cells, they adopt a high anti-inflammatory, low pro-inflammatory cytokine/chemokine
secreting phenotype that is lost if MFG-E8 is absent from the media. Macrophage treatment with recombinant MFG-E8
recapitulates the effect of conditioned media. Finally, we showed that MFG-E8-mediated reprogramming of macrophages
occurs through increased phosphorylation of signal transducer and activator of transcription-3 (STAT-3). Taken together, our
study suggests a key role of MFG-E8 release from apoptotic endothelial cells in macrophage reprogramming and
demonstrates the importance of the apoptotic microenvironment in anti-inflammatory macrophage responses.
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Introduction
Apoptosis, an ubiquitous form of cell death, occurs during
embryogenesis in normal tissues and during inflammation. It has
been classically associated with a silent form of cell dismissal [1].
However, recent evidence suggests that apoptotic cells can
modulate their microenvironment and neighboring cell biology.
Apoptotic cells are known to release ‘‘eat-me’’ and ‘‘find-me’’
signals aimed at coordinating the non-phlogistic recruitment of
professional phagocytes to allow swift clearance of apoptotic cells
and inhibition of neutrophil influx [2,3,4,5,6,7]. Mounting
evidence indicates that the paracrine component of the apoptotic
program is not limited to the regulation of leukocyte trafficking,
but also prepares the cellular microenvironment for remodeling
after apoptotic cell deletion. Apoptotic endothelial cells (EC) are a
key component of the ‘‘response to injury’’ process. It is recognized
that most atherosclerosis risk factors (such as hypertension [8],
hyperglycemia [9] and oxidized low-density lipoproteins [10]) and
antibody-complement-mediated immune injuries [11] induce EC
apoptosis, which can generate a local microenvironment that will
affect cell survival [12,13,14,15], activation [16,17] and differen-
tiation [13,18] of neighboring vascular wall cells. Apoptotic cells
can modify their local environment through classical and non-
classical secretion of various biological agents [15]. However, the
reprogramming consequences of this apoptotic microenvironment
on macrophages have not yet been fully characterized.
Macrophages are essential for initiating both inflammation and
the repair of injured tissues [19]. In inflammation, they respond
destructively to the damage identified; they also promote
resolution of inflammation and contribute to tissue repair [20].
Initiation of inflammation, tissue damage and fibrosis are
promoted by macrophages through reprogramming induced by
the local microenvironment [11,20,21,22,23]. Indeed, the macro-
phage phenotype is affected by various signaling cues that vary
according to the inflammation phase when they are recruited
[20,23]. The injury-inducing and repair-promoting role of
macrophages has been well described: macrophage depletion
during the fibrosis phase reduces scarring, but depletion during
recovery inhibits matrix degradation [24]. Furthermore, there is
evidence to suggest that macrophages have a crucial role in
conditions where endothelial apoptosis is present [25,26,27,28].
The local environment can affect macrophage phenotype and
influence the nature of its inflammatory response. Phenotypes are
dynamic; they can switch from pro-inflammatory to anti-
inflammatory and vice versa [29]. Therefore, two macrophage
phenotypes can be identified: pro-inflammatory (M1) and anti-
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36368inflammatory (M2). Pro-inflammatory M1 macrophages stem
from classical and innate activation. They produce pro-inflamma-
tory cytokines such as tumor necrosis factor, monocyte chemo-
tactic protein-1 (MCP-1) and macrophage inflammatory protein-2
(MIP-2). Anti-inflammatory, pro-repair M2 macrophages derive
from alternative activation or reprogramming induced by the
phagocytosis of apoptotic cells. This phenotype is characterized by
the production of anti-inflammatory molecules such as interleukin-
10 (IL-10), transforming growth factor (TGF)-b1, and vascular
endothelial growth factor (VEGF) [30,31,32]. However, consider-
ing phenotype as described is a simplistic view, as these
macrophage phenotypes represent a continuum where transitional
states are possible [33].
Our previous work, via a proteomic approach, suggested that
milk fat globule-epidermal growth factor 8 (MFG-E8) could be
secreted by apoptotic EC [15]. It could be produced by various
cell types and, essentially, by activated macrophages. MFG-E8 is
crucial for the phagocytosis of apoptotic cells [34] and in
macrophage activation [35,36]. We have further investigated
MFG-E8 release by apoptotic endothelial cells due to its
importance in inflammation and especially in macrophage
function.
Here, we show MFG-E8 release by apoptotic EC. We propose
that apoptotic EC may be the initial cellular source of MFG-E8,
before its production by activated macrophages [34]. Our study
suggests that apoptotic cell-conditioned media contribute to
macrophage reprogramming into anti-inflammatory, pro-repair
macrophages, via MFG-E8 release in a phagocytosis-independent
manner.
Results
Apoptotic endothelial cell-conditioned medium contains
MFG-E8 and could program macrophages
We first assessed whether apoptotic EC could release MFG-E8.
Apoptosis was induced in vitro by serum starvation (SS) for 4 h as
reported previously [12,13,15,37,38]. This model is relevant to
situations where EC apoptosis is found: chronic transplant
vasculopathy and ischemia-reperfusion [11,39]. In our study,
serum-starved human umbilical vein endothelial cells (HUVEC)
(Figure 1a), evaluated with Hoechst 33342 (HO) and propidium
iodide (PI) staining, showed a progressive time-dependent increase
of chromatin condensation in the absence of cell membrane
permeabilization, indicative of apoptosis, as described elsewhere
[12,13,15,37,38]. Necrosis, indicated by cell membrane permea-
bilization (inclusion of PI), was not significantly induced by SS.
Chromatin condensation was present after 2 h of SS (Figure 1a),
concomitantly to caspase-3 activation (Figure 1b, lower panels).
Murine EC (MEC) and HUVEC apoptosis was associated with
MFG-E8 release in the serum starved-conditioned media (SSC)
(Figure 1b, upper panels), whereas the intracellular MFG-E8
content declined in EC, whilst simultaneously exhibiting height-
ened expression of active caspase-3 fragments (Figure 1b, lower
panels). No significant differences were found in MFG-E8 release
between BALB/c and C57BL/6 serum-starved EC (data not
shown). We used mitomycin C (MMC) as another pro-apoptotic
stimulus [15,37]. MMC treatment of EC augmented the
percentage of cells with chromatin condensation and promoted
MFG-E8 release (Figure 1c). Furthermore, MFG-E8 was absent
from media conditioned by necrotic EC suggesting that this
protein is not released passively as a consequence of cell
membrane permeabilization (Figure 1d). Since MFG-E8 can be
secreted as a soluble or as a small membrane vesicle protein (like
exosomes), we then investigated which form serum-starved EC
released MFG-E8. Equal volumes of total unfractionated SSC
were centrifuged at 50 000 g to remove apoptotic bodies and
apoptotic cells. Supernatants and bleb pellets were collected.
Obtained supernatants were then ultracentrifuged at 200 000 g to
sediment small membrane vesicles, the resulting supernatants and
vesicle pellets were harvested. MFG-E8 levels were detected in
total unfractionated SSC, in supernatants from the centrifugation
at 50 000 g and in supernatants from the 200 000 g ultracentri-
fugation (Figure 1e). The small membrane vesicle fraction
contained MFG-E8, but at lower levels than in the supernatants.
MFG-E8 was absent in the apoptotic blebs fraction (Figure 1e).
These results suggest that MFG-E8 is mostly released by apoptotic
EC as a soluble molecule rather than associated to small
membrane vesicles.
To evaluate the phenotypic consequences of SSC on macro-
phage reprogramming, murine bone marrow-derived macrophag-
es (BMDM) were stimulated with SSC for 24 h. Experiments
performed with BMDM from C57BL/6 and BALB/c mice
showed no differences in cytokine production between strains
(data not shown). They produced more TGF-b1, VEGF and IL-10
in response to SSC from apoptotic EC than control serum-starved
macrophages (Figure 1f, left panel, values in Table 1). Further-
more, the production of pro-inflammatory chemokines MCP-1
and MIP-2 was significantly lower with SSC than with SS
exposure (Figure 1f, right panel, values in Table 1). Similar results
were obtained with human monocytes-derived macrophages
(HMDM). TGF-b1 production by HMDM was increased 2.5
times in response to SSC from apoptotic EC compared to serum
starvation alone whereas production of pro-inflammatory cyto-
kines IL-8, MCP-1 and IL-6 were 90%, 93% and 97% reduced
respectively with SSC exposure compared to SS (p,0.001, n=3).
Therefore, macrophages exposed to conditioned media from
serum-starved apoptotic endothelial cells, adopt a high anti-
inflammatory, low pro-inflammatory cytokine/chemokine secret-
ing phenotype.
Caspase-3 activation is necessary for MFG-E8 release and
subsequent macrophage programming
Employing pre-treatment with an irreversible caspase-3 specific
inhibitor, DEVD (SSC-DEVD), to inhibit EC apoptosis before SS,
we investigated whether MFG-E8 liberation was dependent on
caspase-3 activation. As illustrated in Figure 2a (left panel), MFG-
E8 release from serum-starved MEC was greatly reduced after
caspase-3 inhibition using DEVD compared to control (dimethyl-
sulfoxide (DMSO)) pre-treated serum-starved MEC (SSC-
DMSO). As expected, intracellular MFG-E8 levels were higher
in DEVD than in DMSO-treated MEC (Figure 2a right panel).
Furthermore, serum starvation of MEC from caspase-3 knockout
(KO) mice was associated with the absence of MFG-E8 release in
comparison to MEC from wild type (WT) mice (Figure 2b).
Moreover, MEC apoptosis plays a role in macrophage repro-
gramming as the anti-inflammatory phenotype of macrophages
was inhibited when exposed to serum-starved MEC treated with
the caspase-3 inhibitor. As depicted in Figure 2c (left panel), the
production of TGF-b1, VEGF and IL-10 was significantly
decreased in BMDM subjected to SSC-DEVD compared to
SSC-DMSO (Figure 2c, left panel, values in Table 2). However,
we observed increased MCP-1 and MIP-2 production by SSC-
DEVD-treated BMDM versus the control (Figure 2c, right panel,
values in Table 2). Similar results were obtained with HMDM. IL-
8, MCP-1 and IL-6 production were 1.5, 2 and 10 times increased
respectively in response to SSC-DEVD compared to SSC-DMSO
(p,0.001, n=3). These results suggest that caspase-3-dependent
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PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e36368Figure 1. Apoptotic EC-conditioned media contain MFG-E8 and reprogram macrophages. A Percentage of cells with increased chromatin
condensation and cell membrane permeabilization (as evaluated with HO and PI staining) in HUVEC exposed to normal medium with growth factors
without serum (normal serum-starved, NSS) or serum starvation (SS) for 1 h to 4 h (*p,0.001 versus Normal, n=3). Example of HO/PI staining on
serum starved HUVEC for 4 h showing chromatin condensation, right panel. B MEC and HUVEC were serum-starved for 1 h to 4 h. Supernatants
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into an anti-inflammatory phenotype.
MFG-E8 plays an important and sufficient role in
macrophage programming
To clearly establish that macrophage programming in response
to apoptotic MEC is dependent on MFG-E8 release from
apoptotic MEC, we immunoprecipitated MFG-E8 from apoptotic
MEC-conditioned media. Figure 3 demonstrates that the absence
of MFG-E8 significantly inhibited macrophage reprogramming by
apoptotic EC. Indeed, MFG-E8-immunodepleted SSC (Figure 3,
upper panel) attenuated the production of the anti-inflammatory
cytokines TGF-b1, VEGF and IL-10 (Figure 3, lower left panel,
values in Table 3) and increased the production of the pro-
inflammatory chemokines MCP-1 and MIP-2 (Figure 3, lower
right panel, values in Table 3) compared to control.
To further highlight the importance of EC-derived MFG-E8 in
macrophage programming, we studied MEC derived from MFG-
E8 KO mice. Immunoblotting for MFG-E8 content in superna-
tants and cell extracts from serum-starved KO and WT EC
confirmed the absence of MFG-E8 in the KO (Figure 4a). In
addition, immunoblotting revealed similar active caspase-3 levels
in both KO and WT MEC (Figure 4a, right panel). SSC from
MFG-E8 KO mice attenuated the production of anti-inflamma-
tory cytokines TGF-b1 and IL-10 and increased the pro-
inflammatory chemokines, MCP-1 and MIP-2, compared to
SSC from MFG-E8 WT mice (Figure 4b, values in Table 4). SSC
MFG-E8 KO-induced cytokine/chemokine production by mac-
rophages was similar to that observed with the SS control
(Figure 4b, values in Table 4). This suggests that the absence of
MFG-E8 significantly altered macrophage programming by
inducing comparable cytokine/chemokine production as seen in
SS-stimulated macrophages.
To demonstrate the essential role of MFG-E8 in reprogram-
ming macrophage phenotype, we performed studies with recom-
binant murine (rm)MFG-E8 at the same concentration as found in
SSC, 1 ng/ml (data not reported). Macrophages were stimulated
with rmMFG-E8 (1 ng/mL), phosphate buffered saline (PBS)
(vehicle for rmMFG-E8), SS or SSC for 48 h and the supernatants
were harvested. Stimulation of macrophages with rmMFG-E8
increased production of the anti-inflammatory cytokines TGF-b1,
VEGF and IL-10 and decreased the production of pro-
inflammatory chemokines MCP-1 and MIP-2 compared to
control PBS-treated macrophages (Figure 5, values in Table 5).
Chemokine/cytokine production by macrophages treated with
rmMFG-E8 was similar to that seen with SSC-treated macro-
phages. Similar results were obtained with HMDM. TGF-b1
production by HMDM was increased by 46% in response to
rhMFG-E8, whereas production of pro-inflammatory cytokines
IL-8 and MCP-1 were reduced by 73% and 70% respectively with
rhMFG-E8 treatment compared to control PBS-treated macro-
phages (p,0.001, n=2). Taken together, these results demon-
strated the importance of MFG-E8 in the induction of an anti-
inflammatory macrophage phenotype.
Apoptotic endothelial cell-conditioned media activated
the signal transducer and activator of transcription-3
(STAT-3) pathway in macrophages
STAT family of transcription factors are involved in repro-
gramming of macrophages. STAT-1 activation is classically
associated with the pro-inflammatory cytotoxic macrophage
phenotype, whereas STAT-3 activation characterizes the pro-
repair macrophages [20]. We, therefore, studied STAT-3
activation in macrophage reprogramming by apoptosis-condi-
tioned media. Phosphorylated STAT-3 levels were higher after
SSC stimulation compared to SS in BMDM (Figure 6a). We tested
an experimental peritonitis model to assess the vivo reprogramming
of macrophages by SSC. Pre-conditioning of peritoneal leukocytes
with SSC-DMSO for 3 h increased STAT-3 phosphorylation in
the cellular extracts 2 h after the induction of Brewer thioglycol-
late (BTG) peritonitis in mice compared to SSC-DEVD (Figure 6b,
left panel). This, in turn, resulted in increased production of TGF-
b1 and IL-10 (Figure 6b, right panel, see Table 6 for values). In
additional studies, we determined the role of rmMFG-E8 (0.6 mg)
in resident peritoneal macrophage pre-conditioning in STAT-3
activation. The administration of rmMFG-E8 increased the levels
of STAT-3 phosphorylation in immunomagnetically-isolated
peritoneal macrophages compared to PBS and unmanipulated
control, prior to BTG injection. This STAT-3 activation persisted
and increased further after BTG-induced peritonitis in isolated
peritoneal macrophages compared to both controls (Figure 6c),
(upper panels) and cells (lower panels) were harvested. Immunoblotting of MEC protein extracts showed that MFG-E8 levels decreased over time in
parallel with increased active caspase-3 levels (lower left panel). HUVEC also exhibited reduced intracellular MFG-E8 levels over time (lower right
panel). MFG-E8 levels increased over time in serum-starved conditioned medium (SSC) from EC (upper panels). b-Actin and Ponceau red staining were
loading controls. Representative of 3 experiments. C Percentage of cells with increased chromatin condensation and cell membrane permeabilization
(as evaluated with HO and PI staining) in HUVEC exposed to MMC 0.01 mg/mL or vehicle in normal medium and serum starvation (as positive control)
for 15 h (left panel), *p,0.0001 versus vehicle, n=3. Immunoblot for hMFG-E8 in supernatant of EC treated with MMC (right panel). Ponceau red
staining is shown as loading control. Representative of 2 experiments. D Immunoblot for hMFG-E8 in supernatants conditioned by necrotic HUVEC (3
freeze-thaw cycles) and serum-starved HUVEC as positive control. Ponceau red staining included as loading control. Representative of 2 experiments.
E Immunoblot for mMFG-E8 from total medium conditioned by apoptotic EC (Total SSC), supernatant after removal of apoptotic blebs by
centrifugation at 50 000 g (SSC without (W/O) blebs) and apoptotic blebs (Blebs) purified from total SSC by centrifugation, supernatant obtained
from the supernatant after 50 000 g and 200 000 g centrifugation (SSC W/O exo.) and exosome-like nanovesicle fraction pelleted after the 200 000 g
centrifugation (Exo.). Proteins from equal initial volumes were precipitated by TCA. Ponceau red staining is shown as loading control of samples.
Representative of 2 experiments. F MEC were serum-starved for 4 h, the SSC were harvested, centrifuged to remove apoptotic cells. Murine
macrophages were exposed to SSC or serum starvation (SS) for 24 h. ELISA were performed for TGF-b1, VEGF, IL-10, (left panel) MCP-1 and MIP-2
(right panel), *p,0.05, representative of n=14, 12, 4, 7 and 9 separate experiments respectively.
doi:10.1371/journal.pone.0036368.g001
Table 1. Phenotypic analysis of murine bone-marrow-derived
macrophages exposed to SSC vs SS.
TGF-b VEGF IL-10 MIP-2 MCP-1
SSC 703.2627.65 675.7468.95 307.15639.07121.72614.77 474.20614.77
SS 64.29610.99 101.2564.69 49.2365.83 1332.966148.461589.456160.07
Data are presented as value mean 6 SD in pg/mL; SSC: apoptotic serum-starved
conditioned medium; SS: serum-starved medium; TGF: transforming growth
factor; VEGF: vascular endothelial growth factor; IL: interleukin; MIP:
macrophage inflammatory protein; MCP: monocyte chemotactic protein.
doi:10.1371/journal.pone.0036368.t001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e36368Figure 2. Caspase-3 activation is necessary for MFG-E8 release and subsequent macrophage reprogramming. MEC were pre-treated
with an irreversible caspase-3 inhibitor, DEVD-FMK (SSC-DEVD, 100 mM) to prevent apoptosis, and then serum-starved for 4 h. Control MEC were pre-
treated with vehicle (DMSO) for 2 h, washed and serum-starved for 4 h A Murine MFG-E8 was immunoblotted in SSC and cell extracts. DEVD-FMK-
treated murine EC released less MFG-E8 compared to the vehicle (DMSO) (left panel), whereas their intra-cellular content remained higher than
DMSO-treated EC (right panel). Ponceau red and b-Actin were loading controls. Representative of 3 experiments. B Immunoblot for murine MFG-E8 of
SSC from caspase-3 KO EC compared to EC from WT mice. Representative of 2 experiments. C Murine macrophages produced more TGF-b1, VEGF, IL-
10 (left panel) and less pro-inflammatory chemokines MCP-1 and MIP-2 (right panel) when exposed to media where apoptosis was not inhibited.
*p,0.05, representative of n=11, 9, 3, 5 and 8 separate experiments respectively.
doi:10.1371/journal.pone.0036368.g002
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e36368indicating that MFG-E8 activated the STAT-3 pathway. Alto-
gether, these results suggest that STAT-3 activation is present in
the observed anti-inflammatory reprogramming of macrophages.
Discussion
Apoptotic cells release various elements that modify their
microenvironment. This includes numerous chemokines or
chemokine-like compounds, such as lysophosphatidylcholine [3],
fractalkine [40] and nucleotides [41]. Existing evidence indicates
that apoptotic EC induces resistance to apoptosis and contributes
to changes in the phenotype of neighboring vascular wall cells
[12,13]. EC apoptosis, through cathepsin L release, degrades
perlecan and generates the pro-fibrotic fragment LG3 [37].
Recently, other reports have suggested that the apoptotic milieu
could also promote survival [14] and increase the phagocytosis of
apoptotic cells by macrophages [42].
Apoptotic cells could activate classical and non-classical
secretion pathways involving the exosomal release of proteins.
Using proteomic analysis of media conditioned by apoptotic cells,
we have previously suggested that MFG-E8 could be secreted,
perhaps from the exosomal compartment [15]. However, this
observation warranted further evaluation as presented here.
Dendritic cells can secrete MFG-E8 through the release of
exosomes [43]. Macrophages produce MFG-E8 upon activation
whereas resident macrophages do not [34].
Our data highlights caspase-3-dependent MFG-E8 release by
apoptotic EC as the primary source of an important protein
introducing a novel mechanism of macrophage programming by
the microenvironment. This apoptosis-conditioned microenviron-
ment induces a phenotypic switch in macrophages, promoting
anti-inflammatory and pro-repair macrophages, independent of
apoptotic cell phagocytosis-induced reprogramming of macro-
phages. It suggests that, in addition to the anti-inflammatory
function of apoptotic cells per se through their engulfment by
macrophages and subsequent reprograming [30,31], the apoptotic
microenvironment could similarly reprogram the neighboring
resident and recruited macrophages as a consequence of MFG-E8
secretion. Considering the pro-inflammatory mediators that can
be produced by apoptotic EC, such as extra-cellular matrix
fragments [37], a local dampening molecule could be essential to
attenuate the local inflammatory response due to tissue injury.
Apoptotic cells could constitute the initial source of MFG-E8 in
the early inflammatory response, before production by activated
macrophages [34]. The new role we are postulating for MFG-E8
could be important to maintain local tissue homeostasis by cellular
death itself, to promote the pro-repair programming of macro-
phages and ensure the early presence of a potent apoptotic cell-
opsonizing molecule [34]. This would endow MFG-E8 with
another potentially crucial function. Indeed, MFG-E8 is critical for
apoptotic cell phagocytosis [34] and in macrophage biology
[35,36]. During apoptotic cell engulfment, MFG-E8 opsonizes
phosphatidylserine, allowing its recognition by macrophages
through avb3 and avb5 integrins [34]. This process seems to
occur in activated macrophages through a granulocyte-macro-
phage-colony-stimulating-factor induced mechanism of MFG-E8
expression [35]. In response to bacterial lipopolysaccharides (LPS)
stimulation, MFG-E8 has been shown to reduce macrophage
activation by modulating integrin signaling [36]. Data from an
ischemia-reperfusion injury model indicates that MFG-E8 admin-
istration protects mice by promoting apoptotic cell engulfment
[44]. MFG-E8 may bind lung collagen to facilitate its clearance in
pulmonary fibrosis [45]. The role of MFG-E8 in inflammation
extends beyond phagocytosis. Effectively, local release of TGF-b1
and CCL22 through MFG-E8 expression may foster the
recruitment and maintenance of FoxP3+ Tregs, promoting
allograft tolerance [35]. MFG-E8 can modify macrophage
behavior by increasing IL-10 production [36]. Significantly, most
of these studies have implicated macrophages as the main source
of MFG-E8 production and studied its role as an inhibitor of LPS
stimulation. We suggest here that apoptotic cell-conditioned media
and MFG-E8 reprogram macrophages through increased STAT-3
phosphorylation. However, the signaling pathways involved in
STAT-3 activation by MFG-E8 during SS are still unknown. After
LPS treatment, MFG-E8 could induce STAT-3 and suppressor of
cytokine signaling-3 (SOCS3) activation to attenuate the pro-
inflammatory stimulation of macrophages [46]. STAT-3 has
recently been implicated in MFG-E8 stimulation of cancer stem
cells produced by tumor-associated macrophages [47].
In clinical situations, such as transplant vasculopathy and highly
proliferative cancers, where EC apoptosis is important, the
constant presence of apoptotic EC could promote an unregulated
repair response by macrophages with the constant production of
pro-fibrotic and immunosuppressive mediators. This could lead to
tissue fibrosis and/or impaired immune response. Therefore,
better understanding of MFG-E8’s role in macrophage repro-
gramming and associated signaling pathway activated by the
apoptotic cell microenvironment, is central to the development of
new therapeutic approaches in transplantation and cancer biology.
Materials and Methods
Cell culture and generation of conditioned media
Human umbilical vein endothelial cells (HUVECs) (Clonetics,
San Diego, CA, USA) were cultured as described elsewhere [37]
and used at passages 4–5. Serum-free media conditioned by
apoptotic or caspase-inhibited EC, were obtained as described
(42). Equal EC numbers (2.5610
4 cells/cm2) were preincubated
for 2 h in normal medium containing either DMSO (vehicle) or
DEVD-FMK (100 mM) (R&D Systems, Minneapolis, MN, USA)
for caspase-3 inhibition, washed and the culture medium was
changed for serum-free RPMI medium (Wisent, St-Bruno,
Que ´bec, Canada) and then EC were serum-starved for 4 h to
obtain SSC-DMSO and SSC-DEVD respectively. To induce
apoptosis in another way, EC were treated with MMC (0.01 mg/
ml, Sigma, Oakville, Ontario, Canada) for 15 h. Conditioned
Table 2. Caspase-3 dependent production of MFG-E8 in EC reprograms bone-marrow-derived macrophages.
TGF-b VEGF IL-10 MIP-2 MCP-1
SSC-DEVD 151.2864.17 111.4967.89 61.6462.69 417.33642.48 966.94667.87
SSC-DMSO 499.45613.11 160.0668.60 203.25624.90 61.6165.86 431.43637.06
Data are presented as value mean 6 SD in pg/mL; SSC: apoptotic serum-starved conditioned medium; TGF: transforming growth factor; VEGF: vascular endothelial
growth factor; IL: interleukin; MIP: macrophage inflammatory protein; MCP: monocyte chemotactic protein.
doi:10.1371/journal.pone.0036368.t002
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e36368Figure 3. MFG-E8 immunoprecipitation from SSC alters macrophage reprogramming. Serum-Starved Conditioned medium (SSC) from
MEC were treated with an anti-MFG-E8 antibody (or isotype control) to deplete the MFG-E8 content. Immunoblotting of MFG-E8 protein in SSC is
shown for MEC (top panel). BMDM treated with SSC depleted of MFG-E8 produced less TGF-b1, VEGF, IL-10 (lower left panel), and more MCP-1 and
MIP-2 (lower right panel). *p,0.05, representative of n=2, 2, 3, 5 and 3 separate experiments respectively.
doi:10.1371/journal.pone.0036368.g003
Table 3. Immunoprecipitation of MFG-E8 in SSC reduces the anti-inflammatory reprogramming of macrophages by SSC.
TGF-b VEGF IL-10 MIP-2 MCP-1
SSC IP-MFGE8 2401.33634.79 202.78613.12 131.91610.40 3021.53638.68 1743.41641.15
SSC IP-ctl 2849.18660.47 385.23643.70 558.26625.46 2757.97623.73 887.54638.36
Data are presented as value mean 6 SD in pg/mL; SSC: apoptotic serum-starved conditioned medium; TGF: transforming growth factor; VEGF: vascular endothelial
growth factor; IL: interleukin; MIP: macrophage inflammatory protein; MCP: monocyte chemotactic protein.
doi:10.1371/journal.pone.0036368.t003
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e36368media were collected and stored at 220uC. Conditioned media
were centrifuged at 50 kG to eliminate apoptotic bodies. Necrotic
conditioned media were produced by submitting EC to 3 freeze-
thaw cycles. Sequential centrifugation protocol was done with
30 mL of SSC with proteases inhibitors (PMSF, Pepstatine A
2 mM, Leupeptine 2 mM), 10 mL of total SSC unfractioned was
kept. 20 mL of this total SSC was then centrifuged at 50 000 g at
4uC for 15 min, blebs pellets was then resuspend in 20 mL of SS
supplemented of proteases inhibitors and 10 mL were kept aside.
The residual 10 mL were then ultracentrifuged at 200 000 g at
4uC for 18 h. Supernatants were kept and small membrane vesicle
pellets were resuspended in 10 mL of SS supplemented with
proteases inhibitors.
Murine endothelial cell (MEC) isolation
Thoracic aortae were removed surgically from anaesthetized
mice, the endothelial side was placed on Matrigel (BD Bioscience,
Mississauga, Ontario, Canada) for approximately a week, or until
endothelial spreading was sufficient, in Dulbecco’s modified
Eagle’s medium (DMEM) low glucose (Gibco, Burlington,
Ontario, Canada) supplemented with fetal bovine serum
(FBS)(Wisent, St-Bruno, Que ´bec, Canada), calf serum (Gibco,
Burlington, Ontario, Canada), endothelial cell growth supplement
(VWR, Radnor, Pennsylvania, USA), heparine (Sigma, Oakville,
Ontario, Canada), fugizon (Gibco, Burlington, Ontario, Canada)
and penicillin/streptomycin (Wisent, St-Bruno, Que ´bec, Canada).
Figure 4. SSC from MFG-E8 KO mice do not reprogram macrophages into anti-inflammatory macrophages. A MFG-E8 KO or WT MEC
were serum-starved for 4 h. Supernatants and cell extracts were immunoblotted for mMFG-E8 confirming KO status. Caspase-3 activation was similar
between the 2 groups. B Murine macrophages were stimulated with Serum-Starved Conditioned medium (SSC) from MFG-E8 KO or WT EC.
Supernatant were analyzed by ELISA. The results indicate that MFG-E8 in SSC is necessary to induce an anti-inflammatory macrophage phenotype.
*p,0.05, representative of n=5 separate experiments.
doi:10.1371/journal.pone.0036368.g004
Table 4. SSC from MFG-E8 KO mice reduces the anti-
inflammatory reprogramming of macrophages.
TGF-b IL-10 MIP-2 MCP-1
SSC MFG-E8 KO 136.56611.06 140.1168.61 622.70662.00 972.82658.59
SSC MFG-E8 WT 676.93649.23 218.72627.32 209.42619.16 203.65633.51
SS 80.80612.49 124.01612.90 635.39697.45 863.236145.10
Data are presented as value mean 6 SD in pg/mL; SSC: apoptotic serum-starved
conditioned medium; TGF: transforming growth factor; IL: interleukin; MIP:
macrophage inflammatory protein; MCP: monocyte chemotactic protein.
doi:10.1371/journal.pone.0036368.t004
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after dispase treatment and seeded on plastic flasks(BD Bioscience,
Mississauga, Ontario, Canada). Cultured MEC were expanded
between passages 4 and 6 and tested experimentally.
Isolation of blood monocyte-derived macrophages and
preparation of bone marrow-derived macrophages
Peripheral monocytes were isolated from healthy donors by
Ficoll gradient (Wisent, St-Bruno) followed by CD14+ immuno-
magnetic selection (Stem Cell, Vancouver). Both CD14++/
CD162 and CD14low/CD16+ monocyte populations were
collected. HMDM were matured in Iscove DMEM (Gibco,
Burlington, Ontario, Canada) with penicillin/streptomycin (Wi-
sent, St-Bruno, Que ´bec, Canada), glutamine (Wisent, St-Bruno,
Que ´bec, Canada) and 10% decomplemented autologous human
serum for 5–7 days before being exposed to experimental media
for 24 h. Informed written consent was obtained from healthy
donors according to the hospital ethics committee (comite ´
d’e ´thique de la recherche du CHUM). The data were not shown.
Bone marrow-derived macrophages (BMDM) were prepared from
C57BL/6 mice. Bone marrow was isolated from femurs by
standard sterile techniques and matured for 7 days in culture
plastic in Dulbecco’s modified Eagle’s medium (DMEM) (Wisent,
St-Bruno, Que ´bec, Canada) with 10% FBS (Wisent, St-Bruno,
Que ´bec, Canada), penicillin/streptomycin (100 mg/ml) (Wisent,
St-Bruno, Que ´bec, Canada), and 20% L929 cell-conditioned
medium as a source of macrophage-colony stimulating factor.
BMDM were more than 96% positive for the macrophage marker
F4/80 by flow cytometry.
Immunoblotting and reagents
In all experiments, equal volumes of all conditioned media were
concentrated by centrifugation in a 10-kD vivaspin concentrator,
according to the manufacturer’s specifications (Sigma, Oakville,
Ontario, Canada) as described previously [37] or by a trichlor-
oacetic acid (TCA) precipitation protocol of supernatants 9:1,
washed with cold acetone and solubilization in sample buffer [15].
A fixed volume in all conditions was loaded onto gel. Proteins were
separated by SDS-PAGE electrophoresis and transferred to
nitrocellulose membranes. Western blotting was performed [37]
and the membranes probed with anti-human MFG-E8 and anti-
mouse MFG-E8 antibodies (R&D Systems, Minneapolis, MN,
USA and Santa Cruz Biotechnology, Santa Cruz, CA, USA,
respectively). Ponceau red staining of membranes served as
protein-loading control. Proteins were extracted from cell pellets
with protease or phosphatase inhibitor cocktail separated by
electrophoresis, transferred to nitrocellulose or PVDF membranes,
and probed. The membranes were probed with anti-active
caspase-3 (Cell Signaling Technology, Pickering, Ontario, Cana-
da), anti-b actin (Abcam, Cambridge, MA, USA), anti-phospho
STAT3 and STAT3 total antibodies (Cell Signaling Technology,
Pickering, Ontario, Canada).
Fluorescence microscopy for quantification of cells with
chromatin condensation and cell membrane
permeabilization
For fluorescence microscopy, unfixed/unpermeabilized adher-
ent EC were stained with Hoechst 33342 (29-(4-ethoxyphenyl)-5-
(4-methyl-1-piperazinyl)-2.59-bi-1H-benzimidazole) (HO) and PI.
They were grown to confluence in 24-well culture plates (BD
Figure 5. Recombinant murine MFG-E8 recapitulates SSC-induced macrophage reprogramming. Murine macrophages were stimulated
with rmMFG-E8 (1 ng/mL) resuspended in RPMI (SS), vehicle (PBS), SS or SSC for 48 h and supernatant were harvested. rmMFG-E8 induced an anti-
inflammatory macrophage phenotype with an increased production of TGF-b1, VEGF and IL-10 and reduced MCP-1 and MIP-2 compared to the
vehicle control (PBS resuspended in SS). *p,0.05 vs respective controls, mean 6 SD , representative of n=3 separate experiments.
doi:10.1371/journal.pone.0036368.g005
Table 5. rmMFG-E8 reproduces the anti-inflammatory macrophage phenotype.
TGF-b VEGF IL-10 MIP-2 MCP-1
SS+ rmMFG-E8 373.16610.02 470.82653.29 61.1463.69 32.6563.02 154.69610.61
SS+PBS 209.27618.04 107.35634.55 21.9460.70 145.1362.75 483.50627.13
Data are presented as value mean 6 SD in pg/mL; TGF: transforming growth factor; VEGF: vascular endothelial growth factor; IL: interleukin; MIP: macrophage
inflammatory protein; MCP: monocyte chemotactic protein.
doi:10.1371/journal.pone.0036368.t005
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added to a final concentration of 5 mg/ml immediately before
fluorescence microscopy analysis (excitation filter I=360–
425 nm). Apoptotic cells show increased HO fluorescence in the
absence of PI positivity. Secondary and primary necrotic cells
present PI positivity.
Enzyme-linked immunosorbent assay (ELISA)
Human IL-6, -8, active TGF-b1, MCP-1 protein levels, as well
as murine IL-10, MCP-1, macrophage inflammatory protein-2
(MIP-2) and vascular endothelial growth factor (VEGF) were
measured by ELISA) according to the supplier’s protocol (BD
Figure 6. STAT-3 activation in macrophage reprogramming by apoptosis-conditioned media. A BMDM were stimulated with Serum-
Starved Conditioned medium (SSC) or serum starvation (SS) for 30 minutes to 1 h. Total protein extracts were harvested and immunoblotted for
phospho-STAT-3, STAT-3 and b-actin as loading control. Phosphorylated STAT-3 levels are higher after SSC stimulation compared to SS.
Representative of 4 experiments. B C57BL/6 mice were pre-conditioned with SSC-DEVD or SSC-DMSO intraperitoneally for 3 h. Experimental
peritonitis was induced with thioglycollate for 2 h and followed by peritoneal lavage to harvest peritoneal cellular exudates and supernatants. Protein
extracts from the cellular exudates showed increased STAT-3 phosphorylation in mice pre-conditioned with SSC-DMSO compared to SSC-DEVD (B,
left panel). ELISA of the supernatants revealed that SSC-DMSO pre-treatment increased TGF-b1 and IL-10 production compared to SSC-DEVD (B, right
panel). *p,0.05, representative of n=3 separate experiments. C MFG-E8 pre-conditioning increased STAT-3 phosphorylation compared to PBS pre-
conditioned or control immunomagnetically-isolated peritoneal macrophages prior to Brewer thioglycollate (BTG) administration (W/O BTG). STAT-3
activation persisted and increased further 2 h following the induction of BTG peritonitis (BTG) in pre-conditioned macrophages. Total STAT-3 levels
are depicted. b-Actin were loading controls. Representative of 2 experiments.
doi:10.1371/journal.pone.0036368.g006
Table 6. Apoptosis-conditioned media in vivo pre-




Data are presented as value mean 6 SD in pg/mL; SSC: apoptotic serum-starved
conditioned medium; TGF: transforming growth factor; IL: interleukin.
doi:10.1371/journal.pone.0036368.t006
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Minneapolis, MN, USA).
MFG-E8 immunoprecipitation from MEC and HUVEC SSC
SSC were incubated with specific antibodies against MFG-E8
or control antibody for 6 h. Protein A/G linked beads were
incubated overnight at 4uC under agitation. SSC were then
centrifuged and immunoblotted for MFG-E8 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA).
Recombinant murine MFG-E8
BMDM matured for 7 days were stimulated with rmMFG-E8
(R&D Systems, Minneapolis, MN, USA) 1 ng/mL in serum-free
media (Wisent, St-Bruno, Que ´bec, Canada) for 48 h. PBS added
to serum-free media (Wisent, St-Bruno, Que ´bec, Canada) served
as negative control. Cytokines/chemokines from the supernatants
were evaluated by ELISA.
Experimental animals and induction of experimental
peritonitis
C57BL/6 and BALB/c mice were bought from Charles River
(Canada). We acquired the MFG-E8 KO mice on the C57BL/6
background were generously donated to us by Professor S. Nagata.
Caspase-3 KO mice were obtained from Jackson Laboratory.
Mice were housed in CRCHUM animal facilities. They were
injected intraperitoneally (IP) with 0.5 mL of conditioned media or
rmMFG-E8 (0.6 mg) for 3 h and then injected with 3% Brewer’s
thioglycollate (BTG) (Difco) and underwent peritoneal lavage with
5 mL of phosphate buffered saline (PBS) (Wisent, St-Bruno,
Que ´bec, Canada) at 2 h thereafter. Peritoneal lavage fluid was
centrifuged and stored at 280uC until analyzed for cytokine/
chemokine production by ELISA. Macrophages were immuno-
magnetically-isolated with magnetic beads (Miltenyi Biotech,
Auburn, CA, USA) after the peritoneal lavages and kept for
immunoblotting. Performed animal experiments were approved
by our institutional Animal Care Committee (Comite ´ institution-
nel de protection des animaux, CRCHUM).
Statistical analysis
The results are expressed as mean 6 SD were analyzed by
Student’s T-test (with Bonferroni correction when appropriate) or
ANOVA, as appropriate. p,0.05 was deemed to be significant for
all tests.
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